Ocugen
Develops modifier gene therapies for inherited and degenerative blindness diseases.
$1.35
After-hours close+0.03 (+2.27%)
At close$1.32(−3.65%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.06 | — | — |
| Aug 2026 | −$0.05 | −$0.07 | −31.3% |
| May 2026 | −$0.05 | −$0.06 | −20.0% |
| Mar 2026 | −$0.06 | −$0.06 | 0.0% |
| Nov 2025 | −$0.06 | −$0.07 | −21.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.06 | — | — | $1.1M | — | — |
| Aug 6, 2026 | −$0.05 | −$0.07 | −31.3% | $888.8K | $1.5M | +67.4% |
| May 5, 2026 | −$0.05 | −$0.06 | −20.0% | $417.8K | $1.5M | +266.9% |
| Mar 4, 2026 | −$0.06 | −$0.06 | 0.0% | $1.1M | −$193.0K | −118.0% |
| Nov 5, 2025 | −$0.06 | −$0.07 | −21.7% | $440.0K | $1.8M | +298.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 1, 2025 | ||||||
| May 9, 2025 | ||||||
| Mar 5, 2025 | ||||||
| Nov 8, 2024 | ||||||
| Aug 8, 2024 | ||||||
| Apr 16, 2024 | ||||||
| Mar 26, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 21, 2023 | ||||||
| May 5, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 5, 2022 | ||||||
| May 6, 2022 | ||||||
| Feb 25, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 6, 2021 | ||||||
| May 7, 2021 | ||||||
| Mar 18, 2021 | ||||||
| Nov 6, 2020 | ||||||
| Aug 14, 2020 | ||||||
| May 8, 2020 | ||||||
| Mar 27, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 9, 2019 | ||||||
| May 15, 2019 | ||||||
| Mar 22, 2019 | ||||||
| Nov 8, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 10, 2018 | ||||||
| Mar 15, 2018 | ||||||
| Nov 9, 2017 | ||||||
| Aug 10, 2017 | ||||||
| May 11, 2017 | ||||||
| Mar 16, 2017 | ||||||
| Nov 10, 2016 | ||||||
| Aug 11, 2016 | ||||||
| May 12, 2016 | ||||||
| Mar 10, 2016 | ||||||
| Nov 12, 2015 | ||||||
| Aug 12, 2015 | ||||||